Form 4: Cibus Inc. Director Gerhard Prante Sells Shares Under 10b5-1 Trading Plan

Director Gerhard Prante of Cibus Inc. sold 2,300 shares of Class A Common Stock in two transactions under a pre-arranged 10b5-1 trading plan.

Summary

• Gerhard Prante, a director at Cibus Inc., sold 1,150 shares of Class A Common Stock on January 3, 2025, at a price of $2.89 per share.
• He then sold another 1,150 shares of Class A Common Stock on January 6, 2025, at a price of $3.14 per share.
• These sales were executed automatically under a Rule 10b5-1 trading plan that was adopted on August 16, 2024.
• Following these transactions, Prante's direct ownership of Class A Common Stock decreased from 50,257 to 49,107 shares.

Sentiment

Score: 5

Explanation: The document reflects a routine transaction under a pre-arranged trading plan, which is neither particularly positive nor negative. It's a neutral event from an investment perspective.

Risks

• The sales by a director could be perceived negatively by the market, potentially impacting the stock price.

Industry Context

Sales by insiders are a common occurrence and are often pre-planned to avoid accusations of insider trading. The use of a 10b5-1 plan is a standard practice for corporate insiders.

Comparison to Industry Standards

• The use of a 10b5-1 trading plan is a common practice among corporate insiders at publicly traded companies, such as those in the biotechnology sector like Cibus Inc.
• These plans allow insiders to sell shares at predetermined times and prices, mitigating the risk of insider trading allegations.
• The volume of shares sold by Gerhard Prante is relatively small compared to the total outstanding shares of Cibus Inc., which is typical for routine sales under such plans.
• Similar sales are often seen at companies like Bayer, Corteva, and other agricultural biotechnology firms, where executives and directors may have significant stock holdings.

Stakeholder Impact

• The sales by a director could cause a slight negative sentiment among shareholders, although the impact is likely to be minimal due to the pre-planned nature of the transactions.

Key Dates

Keywords

Cibus Inc., Gerhard Prante, insider trading, Form 4, stock sale, Rule 10b5-1, director, Class A Common Stock